Page last updated: 2024-10-31

mianserin and Carcinoma, Squamous Cell

mianserin has been researched along with Carcinoma, Squamous Cell in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uzawa, K1
Kasamatsu, A1
Shimizu, T1
Saito, Y1
Baba, T1
Sakuma, K1
Fushimi, K1
Sakamoto, Y1
Ogawara, K1
Shiiba, M1
Tanzawa, H1
Hannon, B1
Fitzgerald, P1
Murphy, M1

Other Studies

2 other studies available for mianserin and Carcinoma, Squamous Cell

ArticleYear
Suppression of metastasis by mirtazapine via restoration of the Lin-7C/β-catenin pathway in human cancer cells.
    Scientific reports, 2014, Jun-25, Volume: 4

    Topics: Adrenergic alpha-Antagonists; Animals; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cel

2014
Treatment of depression as part of end-of-life care.
    BMJ case reports, 2008, Volume: 2008

    Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carcinoma, Squamou

2008